Safety, Tolerability, and Pharmacokinetics of Switching From Oral Risperidone to Risperidone Implant
Clinical trial NCT04418466 · COMPLETED
Trial details
- NCT number
- NCT04418466
- Sponsor
- Delpor, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-01
- Primary completion
- 2023-02-10
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.